Nutritional supplementation for older adults with hip fractures
Can Complex Carbohydrates and Essential Amino Acid Supplementation Improve Outcomes Following Geriatric Hip Fractures
This study tests whether a special nutritional supplement can help older adults with hip fractures keep their muscle strength during recovery compared to regular nutritional advice.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 118 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT06773000 on ClinicalTrials.gov |
What this trial studies
This clinical trial compares the outcomes of older adults with hip fractures who receive a specific nutritional supplement to those who receive standard nutritional counseling. Participants will be randomly assigned to either the supplement group or the control group and monitored for muscle loss through ultrasound measurements of the rectus femoris muscle in the uninjured leg. The study aims to determine if the nutritional supplement can effectively reduce muscle loss during the recovery period following surgery.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 65 years or older who have sustained a geriatric hip fracture requiring surgical intervention.
Not a fit: Patients with pre-existing mobility impairments or severe organ dysfunction may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help improve recovery outcomes and reduce muscle loss in older adults after hip fractures.
How similar studies have performed: Other studies have shown promising results with nutritional supplementation in similar populations, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male or female, aged 65 years or older. 2. Presenting with a geriatric hip fracture (femoral neck, intertrochanteric, or subtrochanteric) requiring surgical intervention. 3. Able to provide informed consent. 4. Expected to survive at least 6 months after surgery, with no terminal illness. Exclusion Criteria: 1. Pre-existing conditions that significantly impair mobility prior to injury. 2. Severe renal or liver impairment. 3. Active treatment with investigational drugs or participation in another clinical trial within the last 30 days. 4. Inability to tolerate oral nutritional supplementation due to gastrointestinal disorders. 5. Allergies to any components of the nutritional supplement being tested.
Where this trial is running
New York, New York
- NYU Langone Health — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Abhishek Ganta, MD — NYU Langone Health
- Study coordinator: Abhishek Ganta, MD
- Email: Abhishek.ganta@nyulangone.org
- Phone: (951) 492-8945
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.